|
|
|
Zapata-Benavides P, Thompson-Armendariz FG, Arellano-Rodríguez M, Franco-Molina MA, Mendoza-Gamboa E, Saavedra-Alonso S, Zacarias-Hernández JL, Trejo-Avila LM, Rodríguez-Padilla C. shRNA-WT1 potentiates anticancer effects of gemcitabine and cisplatin against B16F10 lung metastases in vitro and in vivo. In Vivo. 2019; 33 (3): 777-785. doi: 10.21873/invivo.11539. print ISSN: 0258-851X, online ISNN: 1791-7549).
|
|
|
|
|
|
Ramos-Zayas Y, Franco-Molina MA, Hernández-Granados AJ, Zárate-Triviño DG, Coronado-Cerda EE, Mendoza-Gamboa E, Zapata-Benavides P, Ramírez-Romero R, Santana-Krymskaya SE, Tamez-Guerra R, Rodríguez-Padilla C. Immunotherapy for the treatment of canine transmissible venereal tumor based in dendritic cells pulsed with tumoral exosomes. Immunopharmacology and Immunotoxicology. 2018 Oct 18: 1-21. doi: 10.1080/08923973.2018.1533969. (online ISSN: 1532-2513, print ISSN: 0892-3973).
|
|
|
|
|
|
Alex Jesús Hernández-Granados, Moisés Armides Franco-Molina, Erika Evangelina Coronado-Cerda, Pablo Zapata-Benavides, Edgar Mendoza-Gamboa, Yareellys Ramos-Zayas, Silvia Elena Santana-Krimskaya, Cristina Rodríguez-Padilla. Immunogenic potential of three transmissible venereal tumor cell lysates to prime canine-dendritic cells for cancer immunotherapy. Research in Veterinary Science. 2018. doi: 10.1016/j.rvsc.2018.10.001. online ISSN: 0034-5288; ISSN: 1532-2661.
|
|
|
|
|
|
Franco-Molina MA, Ramos-Zayas Y, Coronado-Cerda EE, Mendoza-Gamboa E, Zapata-Benavides P, Santana-Krymskaya SE, Tamez-Guerra R, Rodríguez-Padilla C. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate. Immunopharmacology and Immunotoxicology. 2018 Dec 3:1-7. doi: 10.1080/08923973.2018.1523928. (online ISSN: 1532-2513, print ISSN: 0892-3973).
|
|
|
|
|
|
Moises A. Franco-Molina, Silvia E. Santana-Krímskaya, Erika E. Coronado Cerda, Carlos Eduardo Hernández-Luna, Diana G. Zarate-Triviño, Pablo Zapata-Benavides, Edgar Mendoza-Gamboa, María C. Rodríguez-Salazar, Reyes Tamez-Guerra & Cristina Rodríguez-Padilla. Increase of the antitumour efficacy of the biocompound IMMUNEPOTENT CRP by enzymatic treatment. Biotechnology & Biotechnological Equipment. (2018) Vol 32 (4): 1028-1035. ISSN: 1310-2818 (Print) 1314-3530 (Online) Journal homepage: http://www.tandfonline.com/loi/tbeq20. DOI: 10.1080/13102818.2018.1460622
|
|
|
|
|
|
Rodríguez-Salazar M.C., Franco-Molina M. A., Mendoza-Gamboa E., Martínez-Torres AC, Zapata-Benavides P., López-González J Sullivan, Coronado-Cerda EE, Alcocer-González JM, Taméz-Guerra RS, and Rodríguez-Padilla C. A novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the immunogenic cell death and prevented the melanoma growth. Oncology Letters. (2017); 14: 844-852. Print ISSN: 1792-1074. Online ISSN: 1792-1082. 2015 Impact Factor: 1.482
DOI: 10.3892/ol.2017.6202
|
|
|
|
|
|
Franco-Molina Moisés Armides, Mendoza-Gamboa Edgar, Coronado-Cerda Erika Evangelina, Zarate-Triviño D, Arizpe-Coronado Juan Eduardo, Zapata-Benavides Pablo, Ramos-Zayas Y, Tamez-Guerra Reyes S, and Rodríguez-Padilla Cristina. Clinical trial evaluating the effectiveness of biocompound IMMUNEPOTENT CRP in the third molar extraction. Biotechnology & Biotechnological Equipment 2017; 31 (1): 182-186. Published online 01 Nov 2016. (online ISSN: 1314-3530, print ISSN: 1310-2818, Impact Factor: 1.604). DOI: 10.1080/13102818.2016.1249408.
|
|
|
